Exacerbation of chronic active Epstein-Barr virus infection in a patient with rheumatoid arthritis receiving humanised anti-interleukin-6 receptor monoclonal antibody [3]

Annals of the Rheumatic Diseases

Volumn 65, Issue 12, 2006, Pages 1667-1669

  Ogawa, J ^a   Harigai, M ^a   Akashi, T ^a   Nagasaka, K ^b   Suzuki, F ^a   Tominaga, S ^c   Miyasaka, Nobuyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Ohme Municipal General Hospital   (Japan)

^c YOKOSUKA KYOSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATLIZUMAB; CORTICOSTEROID; CYCLOSPORIN A; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 6 RECEPTOR; METHOTREXATE; MONOCLONAL ANTIBODY;

ADULT; ANAMNESIS; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHRONIC DISEASE; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; RECEPTORS, INTERLEUKIN-6;

EID: 33751284575     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.054197     Document Type: Letter

References (8)

1. Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 2004;50:1761-9.
2. Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001;98:280-6.
3. Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005;80:64-9.
4. Savoldo B, Huls MH, Liu Z, Okamura T, Volk HD, Reinke P, et al. Autologous Epstein-Barr virus (EBV) specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood 2002;100;4059-66.
5. Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res 2002;4(Suppl 3):S233-42.
6. Kishimoto T, Hibi M, Murakami M, Narazaki M, Saito M, Taga T. The molecular biology of interleukin 6 and its receptor. Ciba Found Symp 1992;167:5-23.
7. Kishimoto T. The biology of interleukin-6. Blood 1989;74:1-10.
8. Okada M, Kitahara M, Kishimito S, Mtsuda T, Hirano T, Kishimoto T. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 1988;141:1543-9.